What is a stock summary page? Click here for an overview.
Business Description
Endymed Ltd
NAICS : 334510
SIC : 3842
ISIN : IL0011010217
Compare
Compare
Traded in other countries / regions
ENDY.Israel IPO Date
2007-01-29Description
Endymed Ltd is a medical technology company that designs, develops, and commercializes energy based aesthetic treatment systems for the professional markets. It offers energy based medical aesthetic treatment systems for professional and consumer markets. It provides solution for nonablative and fractional tightening and contouring treatments for the face, neck and body, acne scar and stretchmark treatment, cellulite reduction and RF Microneedling treatments.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.1 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.77 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 2.34 | |||||
| Beneish M-Score | -2.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.5 | |||||
| 3-Year EBITDA Growth Rate | 22.8 | |||||
| 3-Year EPS without NRI Growth Rate | 20.4 | |||||
| 3-Year Book Growth Rate | 21.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.8 | |||||
| 9-Day RSI | 65.6 | |||||
| 14-Day RSI | 64.07 | |||||
| 3-1 Month Momentum % | 0.23 | |||||
| 6-1 Month Momentum % | 21.26 | |||||
| 12-1 Month Momentum % | -1.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.05 | |||||
| Quick Ratio | 2.58 | |||||
| Cash Ratio | 1.87 | |||||
| Days Inventory | 205.04 | |||||
| Days Sales Outstanding | 28.09 | |||||
| Days Payable | 55.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -0.16 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.26 | |||||
| Operating Margin % | -10.73 | |||||
| Net Margin % | -9.6 | |||||
| FCF Margin % | -12.26 | |||||
| ROE % | -12.44 | |||||
| ROA % | -9.17 | |||||
| ROIC % | -22.91 | |||||
| 3-Year ROIIC % | 0.25 | |||||
| ROC (Joel Greenblatt) % | -37.42 | |||||
| ROCE % | -12.2 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.63 | |||||
| PB Ratio | 0.92 | |||||
| Price-to-Tangible-Book | 0.93 | |||||
| EV-to-EBIT | -3.32 | |||||
| EV-to-EBITDA | -4.34 | |||||
| EV-to-Revenue | 0.34 | |||||
| EV-to-FCF | -2.78 | |||||
| Price-to-GF-Value | 1.05 | |||||
| Price-to-Projected-FCF | 0.77 | |||||
| Price-to-Net-Current-Asset-Value | 1.19 | |||||
| Price-to-Net-Cash | 6.04 | |||||
| Earnings Yield (Greenblatt) % | -30.12 | |||||
| FCF Yield % | -19.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Endymed Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 68.637 | ||
| EPS (TTM) (₪) | -0.482 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.39 | ||
| 3-Year Sortino Ratio | -0.55 | ||
| Volatility % | 58.04 | ||
| 14-Day RSI | 64.07 | ||
| 14-Day ATR (₪) | 0.025861 | ||
| 20-Day SMA (₪) | 3.1769 | ||
| 12-1 Month Momentum % | -1.1 | ||
| 52-Week Range (₪) | 1.9 - 3.55 | ||
| Shares Outstanding (Mil) | 13.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Endymed Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Endymed Ltd Stock Events
| Event | Date | Price (₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
Endymed Ltd Frequently Asked Questions
What is Endymed Ltd(XTAE:ENDY)'s stock price today?
The current price of XTAE:ENDY is ₪3.20. The 52 week high of XTAE:ENDY is ₪3.55 and 52 week low is ₪1.90.
When is next earnings date of Endymed Ltd(XTAE:ENDY)?
The next earnings date of Endymed Ltd(XTAE:ENDY) is .
Does Endymed Ltd(XTAE:ENDY) pay dividends? If so, how much?
Endymed Ltd(XTAE:ENDY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers